Lawver Teri L
SEC insider (Form 3/4/5 filer). CIK 0001960596. SVP & Chief Commercial Officer at Celldex Therapeutics, Inc. (CLDX) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2026. Located in HAMPTON, NJ.
Companies Lawver Teri L has filed insider reports for
- Celldex Therapeutics, Inc. (CLDX): Officer, SVP & Chief Commercial Officer
- Altimmune, Inc. (ALT): Director
Lawver Teri L
CIK: 0001960596
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 25, 2026CLDX
Celldex Therapeutics, Inc.
AwardDirectIncentive Stock Option (right to buy)
90K shares- - May 1, 2026ALT
Altimmune, Inc.
AwardDirectStock Options (option to buy)
48.8K shares- - Nov 10, 2025CLDX
Celldex Therapeutics, Inc.
AwardDirectISO (right to buy)
100K shares- - Sep 25, 2025ALT
Altimmune, Inc.
AwardDirectStock Options (option to buy)
48.8K shares- - Feb 24, 2025ALT
Altimmune, Inc.
AwardDirectStock Options (option to buy)
69.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 |  CLDX Celldex Therapeutics, Inc. | Award Incentive Stock Option (right to buy) | 90,000 | - | - | Direct |
| May 1, 2026 |  ALT Altimmune, Inc. | Award Stock Options (option to buy) | 48,800 | - | - | Direct |
| Nov 10, 2025 | CLDX Celldex Therapeutics, Inc. | Award ISO (right to buy) | 100,000 | - | - | Direct |
| Sep 25, 2025 | ALT Altimmune, Inc. | Award Stock Options (option to buy) | 48,800 | - | - | Direct |
| Feb 24, 2025 | ALT Altimmune, Inc. | Award Stock Options (option to buy) | 69,800 | - | - | Direct |
1-5 of 5 transactions